Localized tetanus in immunized mice

NeuroToxicology

Volumn 30, Issue 4, 2009, Pages 697-701

  Fishman, Paul S ^a,b,c   Parks, Deborah A ^a   Bowen, Thomas ^a   Matthews, Christopher C ^a,c  

^a Research Service   (United States)

^b Maryland VAHCS   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Immunity; Motor; Tetanus toxin

Indexed keywords

TETANUS ANTIBODY; TETANUS TOXIN; TETANUS TOXOID;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG POTENCY; GASTROCNEMIUS MUSCLE; MALE; MOTOR ACTIVITY; MOTOR PERFORMANCE; MOUSE; NERVE EXCITABILITY; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; TETANUS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; INJECTIONS, INTRAMUSCULAR; MALE; MICE; MICE, INBRED C57BL; MOTOR ACTIVITY; TETANUS; TETANUS TOXIN; TIME FACTORS; VACCINATION;

ANIMALIA; MUS;

EID: 67651095780     PISSN: 0161813X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuro.2009.05.004     Document Type: Article

References (33)

1. Benecke R., Takano K., Schmidt J., and Henatsch H. Tetanus toxin induced actions on spinal Renshaw cells and Ia-inhibitory interneurones during development of local tetanus in the cat. Exp Brain Res 27 (1977) 271-286
2. Berger S.A., Cherubin C.E., Nelson S., and Levine L. Tetanus despite pre-existing anti-tetanus antibody. JAMA 240 (1978) 769-770
3. Bleck T.P. Tetanus: pathophysiology, management, and prophylaxis. Dis Mon 37 (1991) 545-603
4. Brooks V.B., Curtis D.R., and Eccles J.C. The action of tetanus toxin on the inhibition of motoneurones. J Physiol 135 (1957) 655-672
5. Chance R.E., Root M.A., and Galloway J.A. The immunogenicity of insulin preparations. Acta Endocrinol Suppl (Copenh) 205 (1976) 185-198
6. Chargelegue D., Drake P.M., Obregon P., Prada A., Fairweather N., and Ma J.K. Highly immunogenic and protective recombinant vaccine candidate expressed in transgenic plants. Infect Immunol 73 (2005) 5915-5922
7. Christiansen G. Quantification of tetanus anti-toxin by toxin neutralization test in mice. A comparison between lethal and paralytic techniques. J Biol Stand 9 (1981) 453-460
8. Crone N.E., and Reder A.T. Severe tetanus in immunized patients with high anti-tetanus titers. Neurology 42 (1992) 761-764
9. Fairweather N.F., Lyness V.A., and Maskell D.J. Immunization of mice against tetanus with fragments of tetanus toxin synthesized in Escherichia coli. Infect Immunol 55 (1987) 2541-2545
10. Farrell R.A., and Giovannoni G. Measuring and management of anti-interferon beta antibodies in subjects with multiple sclerosis. Mult Scler 13 (2007) 567-577
11. Fellows S.J., Kaus C., and Thilmann A.F. Voluntary movement at the elbow in spastic hemiparesis. Ann Neurol 36 (1994) 397-407
12. Fezza J.P., Howard J., Wiley R., Wesley R.E., Klippenstein K., and Dettbarn W. The effects of tetanus toxin on the orbicularis oculi muscle. Ophthal Plast Reconstr Surg 16 (2000) 101-113
13. Fishman PS, Tetanus toxin. In: Botulinum Toxin: Therapeutic Clinical Practice and Science, Jankovik J, Albanese A, Atassi MZ, Dolly JO, Hallett M, Eds. Elsevier. 2009, p. 406-424.
14. Garcia-Mullin R., and Daroff R.B. Electrophysiological investigations of cephalic tetanus. J Neurol Neurosurg Psychiatry 36 (1973) 296-301
15. Gonzalez-Forero D., Morcuende S., Alvarez F.J., de la Cruz R.R., and Pastor A.M. Transynaptic effects of tetanus neurotoxin in the oculomotor system. Brain 128 (2005) 2175-2188
16. Goonetilleke A., and Harris J.B. Clostridial neurotoxins. J Neurol Neurosurg Psychiatry 75 Suppl 3 (2004) 35-39
17. Hagenaars A.M., van Delft R.W., and Nagel J. Comparison of ELISA and toxin neutralization for the determination of tetanus antibodies. J Immunoassay 5 (1984) 1-11
18. Horstman A.M., Beltman M.J., Gerrits K.H., Koppe P., Janssen T.W., Elich P., and de Haan A. Intrinsic muscle strength and voluntary activation of both lower limbs and functional performance after stroke. Clin Physiol Funct Imaging 28 (2008) 251-261
19. Jagoda A., Riggio S., and Burguieres T. Cephalic tetanus: a case report and review of the literature. Am J Emerg Med 6 (1988) 128-130
20. Johnson E.A. Clostridial toxins as therapeutic agents: benefits of nature's most toxic proteins. Ann Rev Microbiol 53 (1999) 551-575
21. Melville-Smith M.E., Seagroatt V.A., and Watkins J.T. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus anti-toxin in human sera. J Biol Stand 11 (1983) 137-144
22. Newham D.J., and Hsiao S.F. Knee muscle isometric strength, voluntary activation and antagonist co-contraction in the first six months after stroke. Disabil Rehab 23 9 (2001) 379-386
23. Passen E.L., and Andersen B.R. Clinical tetanus despite a protective level of toxin-neutralizing antibody. JAMA 255 (1986) 1171-1173
24. Risk W.S., Bosch E.P., Kimura J., Cancilla P.A., Fischbeck K.H., and Layzer R.B. Chronic tetanus: clinical report and histochemistry of muscle. Muscle Nerve 5 (1981) 363-366
25. Sanders I, 2004. Method for using tetanus toxin for beneficial purposes in animals (mammals). US Patent Application Publication. Pub No. US2004/248188A1.
26. Sasse A., Conduit R., Ryan D., Woods W., and Tucker A.P. A pharmacotherapy for obstructive sleep apnea. Sleep 28 (2005) 1015-1016
27. Scott A.B. Anti-toxin reduces botulinum side effects. Eye 2 (1988) 29-32
28. Schwab M.E., Suda K., and Thoenen H. Selective retrograde transsynaptic transfer of a protein, tetanus toxin, subsequent to its retrograde axonal transport. J Cell Biol. 82 3 (1979) 798-810
29. Sheean G. Botulinum toxin treatment of adult spasticity: a benefit-risk assessment. Drug Safety 29 (2006) 31-48
30. Simpson D.M., Gracies J.M., Graham H.K., Miyasaki J.M., Naumann M., Russman B., Simpson L.L., and So Y. Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70 (2008) 1691-1698
31. Struppler A., Strupler E., and Adams R.D. Local tetanus in man. Its clinical and neurophysiological characteristics. Arch Neurol 8 (1963) 162-178
32. Webster R.A., and Laurence D.R. The effect of anti-toxin on fixed and free toxin in experimental tetanus. J Pathol Bacteriol 86 (1963) 413-420
33. Wiley R.G., and Oeltmann T.N. Anti-ricin antibody protects against systemic toxicity without affecting suicide transport. J Neurosci Methods 27 (1989) 203-209